Penny Stocks on Radar: PBIO, GLXZ, NXOPF, VNNYF

It is often a prudent idea for investors to keep an eye on those stocks that may have already come on their radars. There are some penny stocks that have attracted investors recently. This feature would provide you with a quick look into four penny stocks that you could consider tracking.

Pressure BioSciences Inc. (OTC:PBIO) The company, which is known for the development and sales of broadly enabling high-pressure-based equipment, made a key announcement last Friday. Pressure BioSciences Inc. announced at the time that it had made a major transition in collaborations with some of the most significant innovators in the worldwide biopharmaceutical development and commercialization spaces.

That also included some of the more prominent contract development and manufacturing organizations (CDMOs). The company revealed that it was going to graduate from serial product development and demonstration research contractors to a completely different direction. By way of that step, Pressure BioSciences would move into the installation, sale, and qualification of a research-level BaroFold System.

The global protein therapeutics market is expected to be worth $487 billion by 2030; however, the costs of manufacturing can be very expensive. However, the BaroFold Platform, which already holds 14 patents, can be a cost-effective alternative. The company noted that the first of those BaroFold Systems was being prepared for shipping for the development and research facility of a major worldwide CDMO.

Galaxy Gaming Inc. (OTC: GLXZ): The company is the biggest independent developer and distributor of casino table games and technology. On September 8, Galaxy Gaming Inc. announced that it had entered into a licensing agreement with the firm Konquer for the building and deployment of High Card Flush, High Hand Blackjack, Emperor’s Challenge Exposed, and Daredevil Poker in the North American region.

The President and Chief Executive Officer of the company, Todd Cravens, spoke about the development as well. He noted that everyone at Galaxy Gaming was delighted at the possibility of some of its most progressive and exciting titles being developed for the iGaming market in North America by the team at Konquer. Additionally, he went on to note that it would also be the first time that Emperor’s Challenge Exposed, High Card Flush, and Daredevil would be made available live online. Konquer is well known for providing innovative games and spectacular experiences to its players.

NexOptic Technology Corp. (OTC: NXOPF) The company, which is involved in the development of advanced artificial intelligence and imaging technologies, announced last Friday that it was on the verge of generating its first revenue. NexOptic Technology Corp. entered into an exclusive SaaS (software as a service) partnership with Pristine Surgical LLC. By way of the partnership, the company’s artificial intelligence-powered imaging technology was going to be powered for use in a single-use endoscopic visualization platform named Summit from Pristine.

Summit got its FDA clearance in January of this year, and the first procedure was performed in April. The revenues earned by NexOptic Technology would depend on the number of surgical centers that would use Summit in their surgical processes.

Vinergy Capital Inc. (OTC: VNNYF) Last Friday, the company announced that it had inked a non-binding letter of intent for the acquisition of a stake in a healthcare artificial intelligence company based out of California. Vinergy Capital Inc. revealed that it also had the option to take up exclusive rights to the artificial intelligence platform meant for providing healthcare services.

The potential stake in the artificial intelligence platform would be consistent with the company’s recent investment in the Healthcare Accretion Group, which closed on August 30, 2023. As per the terms of the letter of intent, Vinergy Capital would invest a maximum of $800,000 and issue a maximum of 15 million shares to pick up around 4% of the target company.


Related Posts

About The Author